Clinical TrialID 1601

Anisodamine Critically Ill SeptIc Shock

NCT02442440

Septic Shock

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
1601
Evidence Id
1601
Core Evidence Id
1601
Source Clinical Trial Id
1575
Herb2 Clinical Trial Id
HBCT001575
Nct Id
NCT02442440
Title
Anisodamine Critically Ill SeptIc Shock
Status
Completed
Phase
Phase 1|Phase 2
Study Result
No
Study Condition
Septic Shock
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: anisodamine
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult, Older_Adult
Enrollment
355
Outcome Measure
hospital mortality, the outcome will be assessed by using proportion of patients died, and relative risk will be reported., from ICU admission to hospital discharge (participants will be followed for the duration of hospital stay, an expected average of 28 days)
Sponsor Collaborator
Jinhua Central Hospital
Funded By
OTHER
Location
Huizhou first hospital, Huizhou, Guangdong, 516000, China|Union Hospital, Tongji medical collegue, Huazhong university of Science and Technology, Wuhan, Hubei, China|the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China|affiliated hospital, Jiangsu University, Zhenjiang, Jiangsu, China|Binzhou People's hospital of Shandong province, Binzhou, Shandong, China|department of critical care medicine, Ren Ji Hospital, School of medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, 200001, China|Peace hospital of Changzhi medical college, Changzhi, Shanxi, China|Zhejiang Hospital, Hangzhou, Zhejiang, 310000, China|Sir Run Run Shaw hospital, Hangzhou, Zhejiang, 321000, China|Sir Run Run Shaw hospital, Hangzhou, Zhejiang, China|Jinhua Municipal Central Hospital, Jinhua, Zhejiang, 321000, China|Department of critical care medicine, The central hospital of Lishui City, Lishui, Zhejiang, 323000, China|Beilun People's hospital; The first affiliated hospital of Zhejiang university (Beilun Branch), Ningbo, Zhejiang, China|Taizhou hospital of Zhejiang province, Taizhou, Zhejiang, 317000, China|The first People's hospital of Yongkang, Yongkang, Zhejiang, China
Other Id
2015-013
Start Date
2015-04
Primary Completion Date
2020-10
Completion Date
2020-10-01
First Posted
2015-05-13
Results First Posted
Last Update Posted
2021-09-29
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02442440
Title Cn
Title En
Anisodamine Critically Ill SeptIc Shock
Bilingual Status
semi_complete